Skip to content

Clinical trials

Completed Lymphoma, Large B-Cell, Diffuse trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Completed Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20131
20152
20161
20172
20184
20193
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Celgene3
SymBio Pharmaceuticals3
AbbVie1
Eisai Co., Ltd.1
GlaxoSmithKline1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1
Otsuka Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse18
Lymphoma, Non-Hodgkin7
Lymphoma, B-Cell6
Lymphoma, Follicular6
Lymphoma5
Recurrence5
Lymphoma, Mantle-Cell3
Hematologic Neoplasms2
Neoplasms2
Burkitt Lymphoma1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.